Accolade Inc
NASDAQ:ACCD
Accolade Inc
Other Current Assets
Accolade Inc
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Accolade Inc
NASDAQ:ACCD
|
Other Current Assets
$18.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Other Current Assets
$191.1m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
-10%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Other Current Assets
$251m
|
CAGR 3-Years
15%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-1%
|
|
CVS Health Corp
NYSE:CVS
|
Other Current Assets
$5.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
16%
|
|
Cigna Corp
NYSE:CI
|
Other Current Assets
$8.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Other Current Assets
$678.1m
|
CAGR 3-Years
18%
|
CAGR 5-Years
16%
|
CAGR 10-Years
18%
|
See Also
What is Accolade Inc's Other Current Assets?
Other Current Assets
18.1m
USD
Based on the financial report for Feb 28, 2023, Accolade Inc's Other Current Assets amounts to 18.1m USD.
What is Accolade Inc's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
44%
Over the last year, the Other Current Assets growth was 45%. The average annual Other Current Assets growth rates for Accolade Inc have been 8% over the past three years , 44% over the past five years .